International practice patterns and factors associated with non-conventional hemodialysis utilization by Allen, Nathan et al.
RESEARCH ARTICLE Open Access
International practice patterns and factors
associated with non-conventional hemodialysis
utilization
Nathan Allen
1, Daniel Schwartz
2, Paul Komenda
1, Robert P Pauly
3, Deborah Zimmerman
4, Gemini Tanna
5,
Jeffery Schiff
6, Claudio Rigatto
7 and Manish M Sood
1*
Abstract
Background: The purpose of our study was to determine characteristics that influence the utilization of non-
conventional hemodialysis (NCHD) therapies and its subtypes (nocturnal (NHD), short daily (SDHD), long
conventional (LCHD) and conventional hemodialysis (CHD) as well as provider attitudes regarding the evidence for
NCHD use.
Methods: An international cohort of subscribers of a nephrology education website http://www.nephrologynow.
com was invited to participate in an online survey. Non-conventional hemodialysis was defined as any forms of
hemodialysis delivered > 3 treatments per week and/or > 4 hours per session. NHD and SDHD included both
home and in-centre. Respondents were categorized as CHD if their centre only offered conventional thrice weekly
hemodialysis. Variables associated with NCHD and its subtypes were determined using multivariate logistic
regression analysis. The survey assessed multiple domains regarding NCHD including reasons for initiating and
discontinuing, for not offering and attitudes regarding evidence.
Results: 544 surveys were completed leading to a 15.6% response rate. The final cohort was limited to 311
physicians. Dialysis modalities utilized among the respondents were as follows: NCHD194 (62.4%), NHD 83 (26.7%),
SDHD 107 (34.4%), LCHD 81 (26%) and CHD 117 (37.6%). The geographic regions of participants were as follows:
11.9% Canada, 26.7% USA, 21.5% Europe, 6.1% Australia/New Zealand, 10% Africa/Middle East, 10.9% Asia and
12.9% South America. Variables associated with NCHD utilization included NCHD training (OR 2.47 CI 1.25-4.16),
government physician reimbursement (OR 2.66, CI 1.11-6.40), practicing at an academic centre (OR 2.28 CI 1.25-
4.16), higher national health care expenditure and number of ESRD patients per centre. Hemodialysis providers
with patients on NCHD were significantly more likely to agree with the statements that NCHD improves quality of
life, improves nutritional status, reduces EPO requirements and is cost effective. The most common reasons to
initiate NCHD were driven by patient preference and the desire to improve volume control and global health
outcomes.
Conclusion: Physician attitudes toward the evidence for NCHD differ significantly between NCHD providers and
conventional HD providers. Interventions and health policy targeting these areas along with increased physician
education and training in NCHD modalities may be effective in increasing its utilization.
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The emergence of non-conventional hemodialysis thera-
pies (NCHD), such as nocturnal HD (NHD), short daily
HD (SDHD) and long, thrice weekly (LHD), as dialysis
modalities have resulted in changes to the dialysis pre-
scription on an individual basis. Cardiovascular benefits,
achievement of phosphate and neutral fluid balance and
improvements in quality of life have resulted in a para-
digm shift supporting the increased usage and promotion
of NCHD [1,2]. From a health economics perspective, sub-
types of NCHD such as nocturnal HD have been shown to
be more cost effective than conventional in-centre HD
[3-5]. Despite all these benefits, NCHD continues to have
variable uptake and utilization in many countries.
The decision to initiate non-conventional hemodialysis
is based on several complex patient, physician institu-
tional, and health care payer factors. Barriers to NCHD at
the level of the patient and health care delivery system
have been explored in a few regional studies and mostly
among high income nations [6-8]. Physician-specific rea-
sons for not utilizing this modality have not been well
defined, despite the fact that physicians themselves esti-
mate that approximately 20% of the renal replacement
population would be suitable non-conventional or noctur-
nal HD [9]. This is especially important as in many cen-
tres, the decision to initiate non-conventional HD is most
commonly physician driven.
T h ea i mo ft h ep r e s e n ts t u d yi st oe v a l u a t ep h y s i c i a n
and practice characteristics that influence the utilization
of non-conventional HD and its subtypes of nocturnal,
short daily and long conventional HD in an international
cohort and characterize attitudes regarding initiation of
and the evidence for NCHD use.
Methods
Our survey was distributed to Nephrology Now subscri-
bers with survey methodology and population surveyed
described elsewhere (please see additional file 1 for the ori-
ginal survey instrument) [10,11]. In brief, Nephrology Now
is a non-profit, online, free email alert service that selects
nephrology journal articles and incorporates them into a
monthly mailing list http://www.nephrologynow.com. The
monthly mailing list includes the 15-30 articles with title,
authors, journal and date of publication, a brief summary
and a link to the article abstract. As of April 1, 2011,
Nephrology Now has 3, 498 subscribers from over 150
countries.
Study Population
All subscribers to the Nephrology now monthly mailing
list were contacted by email in the winter of 2011 and
invited to participate in a survey. A total of 3 reminder
emails were sent to all subscribers inviting them to par-
ticipate. Consent was based on participation in the
survey. University of Manitoba regional ethics board
approved this study.
Survey Design
The survey was developed, implemented and tracked using
Survey monkey http://www.surveymonkey.com. Survey
monkey reports the number of survey emails that were
opened (click rate). MMS, DS, PK, NA were primarily
involved in the question development and survey design.
Pre-testing was completed by the survey designers and
other members of the Nephrology Now editorial board.
Outcome and Assessment of Physician Attitudes
The main outcomes measured were utilization of non-
conventional hemodialysis which was defined as “any
forms of hemodialysis delivered > 3 treatments per week
and/or > 4 hours per session” and its subtypes, nocturnal,
short daily and long conventional hemodialysis. NHD and
SDHD included both home and in-centre and each
respondent could identify more than one dialysis modality
available at their centre except for conventional hemodia-
lysis (CHD) which included respondents who offered only
CHD at their centre. Physician attitudes towards efficacy/
evidence, indications for initiating, perceived barriers to
and methods to improve education about NCHD were
assessed and summarized as proportions.
Data Analysis
Demographic, practice and health system differences
among providers and non-providers of NCHD and NHD
were determined by student’s t-test for continuous vari-
ables, chi-square for dichotomous variables and the
Mann-Whitney U test for non-parametric variables. Only
respondents who were physicians were included in the
final analysis. P values < 0.05 were considered significant.
All analyses were conducted using PASW v18 (Texas,
USA).
Covariates associated with the outcomes of NCHD and
its subtypes were assessed for association by logistic
regression. A multivariate model was created with covari-
ate inclusion based in statistical significance on univariate
analysis or an ap r i o r ibelief of their clinical relevance. Sta-
tistically significant changes in the -2 log likelihood were
used to determine variables retained in the final model.
Number of ESRD patients, total health expenditure per
capita and percentage of gross domestic product spent on
health care per capita analyzed as continuous variables
though divided into quartiles for illustrative purposes (See
Figure 1a and 1b).
National data on the total health expenditure per capita
and percentage of gross domestic product spent on health
care per capita was obtained from 2008 core health indica-
tors report at the World Health Organization [12]. The
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states.
Results
A total of 3498 subscribers were invited to participate of
which 1329 surveys were opened (37.9% mean click rate)
and 544 were completed leading to a 15.6% response rate.
The 544 respondents consisted of physicians and non-phy-
sicians and the final cohort included in the analysis was
limited to 311 physicians. Of note, no physician respon-
dents were excluded, only non-physicians. Dialysis modal-
ities utilized among the respondents were as follows:
NCHD 194 (62.4%), NHD 83 (26.7%), SDHD 107 (34.4%),
LCHD 81 (26%) and CHD 117 (37.6%).
Physician and practice characteristics are summarized
in table 1 and 2. The majorities of physicians were
attending staff (83.8%) and worked in urban centres
(91.3%). Slightly over half worked in academic centres
(58.8%) and regularly used PDAs (57.6%). All lengths of
practice and geographic regions were represented with
the majority of respondents from Europe and USA
(21.5% and 26.7% respectively) and few from Australia
and New Zealand (6.1%). The majority of physicians
worked in centres with catchment populations of 500,
000 to 5 million with fewer physicians working in centres
with smaller (8.4%) and larger (4.7%) catchment areas.
Regarding NCHD reimbursement, 74 (23.8%) physicians
were primarily reimbursed by the patient, 102 (32.8%) by
private insurance, and 266 (85.5%) by the government or
public insurance. Greater than one form of reimburse-
ment was possible per physician.
Physicians practicing in Canada, Australia/New Zealand,
in academic centres, with increasing number of ESRD
patients per centre and in catchment areas of 500, 000 to
1 million had significantly more patients on NCHD. Coun-
tries with high national health care expenditures, high per-
centage of GDP expenditure on health care and
government or public physicians’ reimbursement were
more likely to utilize NCHD.
In contrast, CHD only was more common in Asia, South
America and Africa/Middle East and relatively rare in
Canada and Australia/New Zealand. Furthermore, centres
Figure 1 Relationship between Non-conventional hemodialysis and a) National health care expenditure and b) Number of ESRD
patients per centre. Adjusted for academic centre, training, type of reimbursement, country’s health care expenditure.
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publically reimbursed, and had less ESRD patients total
and lower health care expenditure. LCHD was more com-
mon USA and Europe as opposed to Canada
Characteristics associated with NCHD and its subtypes
are presented in tables 3 and 4. In multivariate modeling,
practicing in an academic centre, NCHD training, public
or government physician reimbursement, increasing
national health care expenditures and number of patients
with ESRD per centre were independently associated
with NCHD utilization. Among the subtypes of dialysis,
the number of ESRD patients per centre was consistently
associated with all subtypes of HD. NHD and SDHD
were also associated with health care expenditure. The
relationship between having patients on NCHD and the
number of patients with ESRD per centre and increasing
countries health care expenditures are depicted in
Figures 1a and 1b.
The results of physician attitudes towards the efficacy
and evidence for NCHD are summarized in Figures 2
Table 1 Characteristics of the study cohort stratified by non-conventional hemodialysis (NCHD) and conventional
hemodialysis (CHD) only presented as proportions with actual counts in parentheses
Characteristic Total
%(N)
NCHD
%(N)
CHD only
%(N)
P
Total 62.4(194) 37.6(117)
Level of Training
Staff Physician 83.8 (259) 85.1(165) 81.7(94) 0.5
Fellow 9.6 (30) 7.7(15) 13(15) 0.2
Resident 6.5 (20) 7.2(14) 5.2(6) 0.6
Geographic Region
Canada 11.9 (37) 16.5(32) 4.3(5) 0.001
USA 26.7(83) 32(62) 17.9(21) 0.008
Europe 21.5 (67) 22.7(44) 19.7(23) 0.6
Australia/New Zealand 6.1 (19) 8.8(17) 1.7(2) 0.01
Africa/Middle East 10 (31) 8.2(16) 12.8(15) 0.2
South America 12.9 (40) 7.2(14) 22.2(26) < 0.001
Asia 10.9 (34) 4.6(9) 21.4(25) < 0.001
Smartphone use/personal digital assistant (PDA) 57.6 (179) 61.9(120) 50.4(33) 0.06
Academic Centre 58.8 (181) 66.1(127) 46.6(54) 0.001
Urban 91.3 (284) 92.3(179) 89.7(105) 0.5
Catchment population
< 100 k 8.4 (26) 6.2(12) 12(14) 0.09
100-500 k 37.0 (115) 35.6(69) 39.3(46) 0.5
500-1 million 28.3 (88) 32.5(63) 21.4(25) 0.04
1-5 million 21.5 (67) 21.1(41) 22.2(26) 0.9
> 5 million 4.7 (18) 4.6(9) 5.1(6) 1.0
Length of Practice
1-5 years 29.3 (91) 29.4(57) 29.1(34) 1.0
6-10 years 22.2(69) 25.3(49) 17.1(20) 0.1
11-15 years 13.5(42) 13.4(26) 13.7(16) 1.0
16-20 9.6(30) 13.7(16) 13.4(26) 0.8
> 20 25.4 (79) 22.7(44) 29.9(35) 0.1
Frequent dialysis Reimbursement
Patient primary payer 23.8(74) 23.3(45) 24.8(29) 0.8
Government 85.5(266) 90.7(176) 76.8(90) 0.001
Private insurance 32.8(102) 34.5(67) 29.9(35) 0.5
National healthcare expenditure per capita (median (IQR) in US dollars 3986 (6703) 4409(3418) 663(3619) < 0.001
National healthcare expenditure as percentage GDP (median (IQR)) 8.9(9) 10.1(7.3) 8(5.5) < 0.001
Number of ESRD pts. (median) 150(220) 200(240) 108(138) < 0.001
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improves phosphate control, improves BP control and
improves volume status with greater than 95% of physi-
cians agreeing with each of these statements. In addition,
the majority of physicians agreed that NCHD improves
survival (81%), reduces hospitalizations (79%), and
improves sleep apnea (66%) whether or not they cur-
rently had patients on NCHD. Physicians with patients
on NCHD were significantlym o r el i k e l yt oa g r e ew i t h
the statements that it improves quality of life, improves
nutritional status, and reduces EPO requirements. They
were significantly less likely to agree with the statements
that NCHD increases fistula/graft thrombosis and is too
costly.
Among providers of NCHD, the most common reasons
for HD providers (see Figure 3) were to improve volume
control (44.6%), patient preference (44.1%) and the belief
it improves health in general (41.4%). Other reasons cited
Table 2 Characteristics of the study cohort stratified by nocturnal (NHD), short daily (SDHD), long conventional (LCHD)
and conventional hemodialysis (CHD) prescribers presented as proportions with actual counts in parentheses
Characteristic NHD
%(N)
SDHD
%(N)
LCHD
%(N)
CHD only
%(N)
Total 26.7(83) 34.4(107) 26(81) 37.6(117)
Level of Training
Staff Physician 85.5(71) 84.1(90) 81.5(66) 81.7(94)
Fellow 10.8(9) 8.4(9) 12.3(10) 13(15)
Resident 3.6(3) 7.5(8) 6.2(5) 5.2(6)
Geographic Region
Canada 27.7(23) 19.6(21) 6.2(5) 4.3(5)
USA 31.3(26) 35.5(38) 23.5(19) 17.9(21)
Europe 16.9(14) 23.4(25) 29.6(24) 19.7(23)
Australia/New Zealand 14.5(12) 7.5(8) 8.6(7) 1.7(2)
Africa/Middle East 3.6(3) 4.7(5) 12.3(10) 12.8(15)
South America 2.4(2) 6.5(7) 11.1(9) 22.2(26)
Asia 3.6(3) 2.8(3) 8.6(7) 21.4(25)
Smartphone use/personal digital assistant (PDA) 63.9(53) 61.7(66) 58(47) 50.4(33)
Academic Centre 64.6(53) 68.9(73) 67.5(54) 46.6(54)
Urban 94(78) 94.4(101) 97.5(79) 89.7(105)
Catchment population
< 100 k 2.4(2) 0(0) 2.5(2) 12(14)
100-500 k 39.8(33) 39.3(42) 37(30) 39.3(46)
500-1 million 32.5(27) 34.6(37) 28.4(23) 21.4(25)
1-5 million 22.9(19) 22.4(24) 29.6(24) 22.2(26)
> 5 million 2.4(2) 3.7(4) 2.5(2) 5.1(6)
Length of Practice
1-5 years 24.1(20) 32.7(35) 21(17) 29.1(34)
6-10 years 27.7(23) 25.2(27) 23.5(19) 17.1(20)
11-15 years 21.7(18) 11.2(12) 16(13) 13.7(16)
16-20 8.4(7) 7.5(8) 13.6(11) 13.4(26)
> 20 18.1(15) 23.4(25) 25.9(21) 29.9(35)
Frequent dialysis Reimbursement
Patient primary payer 21.7(18) 19.6(21) 24.7(20) 24.8(29)
Government 91.6(76) 88.8(95) 82.7(67) 76.8(90)
Private insurance 38.6(32) 35.5(38) 34.6(28) 29.9(35)
National healthcare expenditure per capita (median (IQR) in US dollars) 4409 (3299) 4409(3418) 3867(6262) 663(3619)
National healthcare expenditure as percentage GDP (median (IQR)) 10.1(6.8) 10.1(7.3) 8.9(8.1) 8(5.5)
Number of ESRD pts. (median (IQR)) 242(275) 240(250) 200(254) 108(138)
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f i cu r e m i ca r t e r i o p a t h y( c a l c i p h y l a x i s )( 9 . 7 % )o rr e m o t e
patient residence (10.8%).
The reasons for not offering NCHD are summarized in
Figure 4. Lack of availability (60.0%), lack of reimburse-
ment (46.4%), lack of patient interest (31.2%) and lack of
adequate training (17.6%) we r ec o m m o n l yc i t e d .W h e n
providers who cited inadequate training as a barrier to
offering NCHD were asked for their preferred methods
of FHD education online CME (53.9%), conference
(56.5%) or local (47.8%) presentation by an expert and a
review of the primary literature or journal club (507%)
were common responses. Additional fellowship training
(25.4%) and smartphone based CME (18.8%) was sub-
stantially less desirable.
Discussion
Non-conventional forms of hemodialysis are underuti-
lized dialysis modalities despite growing evidence of the
benefits in improving patient outcomes [1-5,13,14].
Understanding physician and practice characteristics that
favorably influence the utilization of NCHD are essential
if it is to be more widely adopted. The present study is
the first international survey to assess physician and prac-
tice specific characteristics associated with NCHD usage.
Practicing in an academic centre, NCHD training, public
or government physician reimbursement increases in
national health care expenditures and numbers of
patients with ESRD per centrew e r ea l li n d e p e n d e n t l y
associated with NCHD utilization.
The association of national health care on increasing
NCHD utilization in our cohort is in contrast to recent
findings by MacGregor et al who found no relationship
between expenditure and NCHD in a registry based
study [9]. Several factors could explain this discrepancy.
The present study examined NCHD and all of its sub-
types including NHD and SDHD. Increases in national
health care expenditure were associated with NHD and
SDHD specifically but not LCHD. In addition, the pre-
sent study included nephrologists from Africa, Asia and
South America while the MacGregor study included
only data from high and middle income countries in
North America, Europe and Australia/New Zealand [9].
Third the methodology in the two studies differed sig-
nificantly and may have led to disparate results; the pre-
sent study was designed to evaluate physician and
practice patterns while the prior study was population
based.
The relationship between health care expenditures and
NCHD was not linear. As shown in Figure 1a, NCHD
Table 3 Characteristics associated with non-conventional hemodialysis (NCHD) usage in a multivariate logistic
regression model.
Characteristic Odds Ratio 95% CI P
Government reimbursement 2.66 1.11-6.40 0.03
Patient reimbursement 1.29 0.61-2.71 0.5
Private insurance reimbursement 1.00 0.47-2.09 1.0
NCHD training 2.47 1.37-4, 43 0.003
Practice at an academic centre 2.28 1.25-4.16 0.007
Number of ESRD patients at centre (per 10 patient increase) 1.03 1.01-1.04 0.002
National health care expenditure 1.0 1.0-1.0 < 0.001
Health expenditure is in US dollars
Table 4 Characteristics associated with nocturnal, short-daily and long conventional hemodialysis usage by
multivariate logistic regression.
Characteristic Odds Ratio 95% CI P
Nocturnal hemodialysis:
Number of ESRD patients at centre (per 10 patient increase) 1.03 1.01-1.04 < 0.001
National health care expenditure 1.00 1.00-1.00 < 0.001
Short daily hemodialysis:
Practice at an academic centre 1.77 0.97-3.22 0.06
Number of ESRD patients at centre (per 10 patient increase) 1.02 1.01-1.04 < 0.001
National health care expenditure 1.0 1.0-1.0 < 0.001
Long conventional hemodialysis:
Number of ESRD patients at centre (per 10 patient increase) 1.01 1.0-1.02 0.08
Health expenditure is in US dollars
Allen et al. BMC Nephrology 2011, 12:66
http://www.biomedcentral.com/1471-2369/12/66
Page 6 of 10utilization was significantly lower in countries in the
lowest quartile of health care expenditures but there
was no significant difference in countries in the top
three quartiles. In fact, countries in the highest quartile
had a subjective decrease in the utilization of NCHD.
Two observations may explain these findings. First,
while NCHD may be more cost-effective in the long-
term it does require higher up-front costs and requires
a significant amount of infrastructure to exist [7]. This
infrastructure often does not exist in countries with the
lowest per capita health care expenditures and the
higher up-front costs are likely prohibitive. Second, the
finding of a subjective decrease in the utilization of FHD
in countries in the highest quartile is likely explained by
an over-representation of nephrologists from the USA
in the present study. Despite the high cost of healthcare
i nt h eU S A ,t h er a t e so fN C H Dr e m a i nq u i t el o wp r i -
marily due to lack of reimbursement schedules that
facilitate home based, or more frequent therapies [15].
In addition, other wealthy countries with higher rates of
utilization of NCHD such as Australia and New Zealand
were under-represented in the present study. Neverthe-
less there appears to be a necessary minimum national
health care expenditure required to allow for NCHD
Figure 2 Physicians attitudes towards the evidence for non-conventional hemodialysis stratified by use or non-use.
Figure 3 Commonly cited indications for initiation of non-conventional hemodialysis among physicians.
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NCHD training appear to influence NCHD usage.
The finding of centre size being associated with more
utilization of NCHD while novel is not surprising and also
did not appear to be linear. There was significantly more
NCHD in centres with greater than 150 ESRD patients
than in those with less. Once this threshold was reached
there was no further increase in NCHD utilization with
increased ESRD patient numbers. Similar findings have
been demonstrated in peritoneal dialysis usage where smal-
ler centres had lower adherence to guidelines, particularly
in the area of continuous quality initiatives [10]. Similar to
continuous quality initiatives which become more difficult
and less economically feasible in a centre with a small
number of patients on peritoneal dialysis, NCHD requires
infrastructure and upfront costs and patient training may
not be possible in centres with small amounts of ESRD
patients. In addition, approximately 6-8% of patients exit
home hemodialysis programs per year [7]. Losing patients
early on in this modality significantly increases per patient
cost and this added cost would be more difficult to absorb
in smaller centres with fewer patients. It would appear that
both economies of scale and economies of scope are more
easily attained with larger programs delivering ESRD care.
NCHD usage is influenced by physician remuneration.
The lack of remuneration for NCHD was commonly
cited as a barrier and was second only to NCHD not
being offered by the health care system. Public healthcare
systems in Australia, New Zealand, the Netherlands and
Canada have instituted programs that encourage and
incentivize NCHD [8]. In Australia, an additional pay-
ment of 128$ per month is provided to physicians mana-
ging patients with home dialysis modalities [9]. Based on
the results of the present study, physician remuneration
and incentives appear to increase utilization of NCHD.
NCHD was associated with practicing in academic
centres and this is likely related to the impression by
some that NCHD was considered an experimental mod-
ality; most patients on FNCHD were managed out of
large research institutions and/or were part of studies
on the potential benefits and or feasibility of NCHD. As
evidence demonstrating a significant clinical benefit for
NCHD mounts and this therapy is adopted by different
healthcare systems these differences are likely to become
less pronounced.
Physician training in NCHD impacted utilization in
our study. Until recently, it is unlikely that physicians
practicing outside a few individual institutions, such as
Tassin, France would have had any exposure to NCHD
[16]. In fact, it was not until approximately 15 years ago
and the pioneering work by Uldall and colleagues in
Toronto, Canada that there was resurgence in interest
in NCHD [17]. Few physicians have formal training in
the safe prescription and patient selection paradigms for
NCHD, limiting physician comfort and exposure to the
potential benefits of this modality. Funding and active
knowledge dissemination regarding NCHD is imperative
if any healthcare system wishes to increase the amount
of patients on NCHD. According to the present study
the preferred methods of achieving this goal would be
through online CME, presentations by experts in NCHD
and through journal club activities.
Finally, the attitudes and opinions of physicians
towards the evidence for NCHD are encouraging for the
future of this modality. There was overall acceptance
among physicians regarding the clinical advantages of
NCHD. There was nearly universal agreement that
NCHD improves phosphate control, BP control and
volume status; outcomes evaluated in 2 recent RCTs
[1,2]. There was significant disagreement about the
Figure 4 Commonly cited barriers to non-conventional hemodialysis usage among users and non-users.
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Page 8 of 10evidence in certain areas. In particular, there was dis-
agreement in the areas of quality of life, nutritional sta-
tus, erythropoietin requirements and graft thrombosis
indicating the need for further research in these areas. At
present evidence remains equivocal, specifically in the
area of complications related to vascular access [1,2]. It
should be noted that Physicians may be reluctant to pre-
scribe NCHD with concerns over the increase in inter-
ventions and use of vascular access. Increased usage of
vascular access in turn may lead to associated complica-
tions and incur health care expenditures. An RCT pow-
ered to demonstrate a mortality difference in NCHD
versus conventional HD is unlikely to ever be performed.
The recently completed NIH funded Frequent Hemodia-
lysis Network RCT in this area encountered significant
logistical barriers to recruitment using surrogate out-
comes. With the majority of surrogate outcomes in the
existing observational and randomized trials favoring
NCHD, the utility of long, expensive RCT’s with mortal-
i t ya sap r i m a r ye n d p o i n ti sq u e s t i o n a b l eg i v e nt h ef a c t
that most of the costing literature in this area have
shown home NCHD to be at least cost neutral, if not
cost saving.
Our study has certain limitations. First it was a voluntary
survey and is therefore prone to selection bias as physi-
cians with no interest in NCHD are less likely to respond.
Our survey depended on self-reported data, the reliability
of which has been questioned and is prone to recall bias.
Our overall response rate was low at 15.6%. This is not
uncommon in internet-based surveys and we attempted to
improve our survey methodology by identifying how many
individuals actually opened the email (click rate). This is
important as many email surveys may be discarded to
junk mail without the contents of the email and purpose
of the survey appropriately conveyed to subscribers. We
included relatively crude expenditure metrics such as
National healthcare expenditure that may not be sensitive
to a country’s efficiencies or capture funding directed
towards specific, specialized health initiatives. Physician
attitudes and opinions were assessed only towards NCHD
and not towards its individual subtypes such as NHD or
SDHD. This limited our ability to identify factors asso-
ciated with NHD, SDHD and LCHD. The survey results
were limited to physicians and did not include health pol-
icy administrators or Allied health, both of whom would
likely influence NCHD utilization. Finally, as previously
discussed, there may have been over-representation of
physicians from the USA and Europe and under-represen-
tation from New Zealand and Australia.
Conclusions
The present study is the first to assess physician and prac-
tice characteristics associated with the utilization of
NCHD in an international cohort. International variations
in the use of NCHD are influenced by training, practicing
in an academic centre, centre size, mode of reimburse-
ment and by national health care expenditures. Interven-
tions and health policy targeting these areas as well as
increased physician education and training in NCHD
modalities may be effective in increasing NCHD utiliza-
tion. In addition, the present study identifies important
areas where significant disagreement exists between prac-
ticing physicians in the realm of NCHD. These areas
require further exploration if NCHD is to be adopted uni-
versally by physicians as a viable dialysis modality.
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